pre-IPO PHARMA

COMPANY OVERVIEW

Alpha Tau Medical is an Israeli MedTech company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.


LOCATION

  • Tel Aviv, , Israel
  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.alphatau.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Mar 7, 2022

    Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination\


    Jan 12, 2021

    Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member USA - English USA - English


    Jun 4, 2020

    Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round English English


    Apr 7, 2020

    Alpha Tau Medical Announces Exclusive Distribution Arrangement With Medison Canada for Breakthrough Cancer Treatment Alpha DaRT English English


    Sep 27, 2019

    Alpha Tau Medical Appoints Professor Yona Keisari as Chief Scientific Officer


    For More Press Releases


    Google Analytics Alternative